In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D

Vox Sanguinis

Volumn 72, Issue 1, 1997, Pages 45-51

  Kumpel, B M ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN A; RHESUS D ANTIBODY;

ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; KILLER CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0031018250     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.00045.x     Document Type: Article

References (28)

1. 4 red blood cells and suppression of Rh D immunization in Rh D volunteers. Blood 1995;86: 1701-1709.
2. Hughes-Jones NC, Mollison PL, Veall N: Removal of incompatible red cells by the spleen. Br J Haematol 1957;3:125-133.
3. Van de Winkel JGJ, Capel PJA: Human IgG Fc receptor heterogeneity; molecular aspects and clinical implications. Immunol Today 1993;14: 215-221.
4. Kumpel BM, Hadley AG: Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines. Mol Immunol 1990;27:247-256.
5. Engelfriet CP: The immune destruction of red cells. Transfus Med 1992;2:1-6.
6. Davenport RD, Kunkel SL: IgG receptor roles in red cell binding to monocytes and macrophages. Transfusion 1994;34(suppl):79S.
7. Mattila PS, Seppala IJT, Eklund J, Makela O: Quantitation of immunoglobulin classes and subclasses in anti-Rh(D) antibodies. Vox Sang 1985;48:350-356.
8. Shaw DR, Conley ME, Knox FJ, Khazaeli MB, LoBuglio AF: Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies. Transfusion 1988;28:127-131.
9. Wiener E, Jolliffe VM, Scott HCF, Kumpel BM, Thompson KM, Melamed MD, Hughes-Jones NC: Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Immunology 1988;65:159-163.
10. Kumpel BM, Leader KA, Merry AH, Hadley AG, Poole GD, Blancher A, Goossens D, Hughes-Jones NC, Bradley BA: Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis. Eur J Immunol 1989;19:2283-2288.
11. Hadley AG, Zupanska B, Kumpel BM, Leader KA: The functional activity of FcγRII and FcγRIII on subsets of human lymphocytes. Immunology 1992;76:446-451.
12. Thomson A, Contreras M, Gorick B, Kumpel B, Chapman GE, Lane RS, Teesdale P, Hughes-Jones NC, Mollison PL: Clearance of Rh D-positive red cells with monoclonal anti-D. Lancet 1990;336:1147-1150.
13. Blancher A, Socha WW, Roubinet F, Rowe AW, Broly H, Byrne P, Holuigue M, Bouzidi A, Huart JJ, Ruffie J: Human monoclonal anti-D-induced clearance of human D-positive red cells in a chimpanzee model. Vox Sang 1993; 65:47-54.
14. Urbaniak SJ, Ayoub Griess M: ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses. Br J Haematol 1980;46:447-453.
15. Zupanska B, Thompson E, Brojer E, Merry AH: Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96-101.
16. Kumpel BM, Poole GD, Bradley BA: Human monoclonal anti-D antibodies. 1. Their production, serology, quantitation and potential use as blood grouping reagents. Br J Haematol 1989; 71:125-129.
17. Burich MA, Anderson HJ, AuBuchon JP: Antibody elution using citirc acid. Transfusion 1986;26:116-117.
18. Kumpel BM: A simple non-isotopic method for the quantitation of red cell-bound immunoglobulin. Vox Sang 1990;59:34-38.
19. Hadley AG, Kumpel BM, Leader K, Merry AH, Brojer E, Zupanska B: An in-vitro assessment of the functional activity of monoclonal anti-D. Clin Lab Haematol 1989;11:47-54.
20. Urbaniak SJ: Lymphoid cell dependent (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. Br J Haematol 1976;33: 409-413.
21. Gunson HH, Thomas DP: Reference preparation for assay of anti-D immunoglobulin. Lancet 1979;i:162.
22. Kumpel BM, van de Winkel JGJ, Westerdaal NAC, Hadley AG, Dugoujon JM, Blancher A: Antigen topography is critical for interaction of IgG2 anti-red cell antibodies with Fcγ receptors. Br J Haematol 1996;94:175-183.
23. Gorick BD, Hughes-Jones NC: Relative functional binding activity of IgG1 and IgG3 anti-D in IgG preparations. Vox Sang 1991;61:251-254.
24. French M: Serum IgG subclasses in normal adults. Monogr Allergy. Basel, Karger, 1986, vol 19, pp 100-107.
25. Goodrick J, Kumpel B, Pamphilon D, Fraser I, Chapman G, Dawes B: Plasma half-lives and bioavailability of human monoclonal Rh D antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D-negative volunteers. Clin Exp Immunol 1994;98:17-20.
26. Jefferis R, Lund J, Pound J: Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR). Mol Immunol 1990;27: 1237-1240.
27. Gergely J, Sarmay G, Rozsnyay Z, Stanworth DR, Klein E: Binding characteristics and isotype specificity of Fc receptors on K cells. Mol Immunol 1986;23:1203-1209.
28. Kumpel BM, Rademacher TW, Rook GAW, Williams PJ, Wilson IBH: Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum Antibodies Hybridomas 1994;5:143-151.